leupeptin has been researched along with palmitic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guccione, MA; Livne, A; Mustard, JF; Packham, MA | 1 |
| Chiou, HC; Hsiao, PJ; Hsieh, TJ; Jiang, HJ; Kuo, KK; Lee, MY | 1 |
2 other study(ies) available for leupeptin and palmitic acid
| Article | Year |
|---|---|
Aggregation-related association of lipid with the cytoskeleton of rabbit and human platelets prelabeled with [3H]palmitic acid. Similar effects of adenosine diphosphate- and thrombin-induced aggregation.
Topics: Actin Cytoskeleton; Adenosine Diphosphate; Animals; Blood Platelets; Calcium; Cyclic AMP; Cytoskeleton; Deoxyribonuclease I; Fibrinogen; Humans; In Vitro Techniques; Leupeptins; Lipid Metabolism; Microscopy, Electron; Palmitic Acid; Palmitic Acids; Platelet Aggregation; Platelet Membrane Glycoproteins; Rabbits; Thrombin | 1988 |
Pioglitazone Enhances Cytosolic Lipolysis, β-oxidation and Autophagy to Ameliorate Hepatic Steatosis.
Topics: Animals; Autophagy; Cell Line; Diet, High-Fat; Disease Models, Animal; Humans; Insulin; Leupeptins; Lipolysis; Male; Mice; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Palmitic Acid; Pioglitazone; PPAR alpha; PPAR gamma; Triglycerides | 2017 |